364 related articles for article (PubMed ID: 25762569)
1. Sodium valproate increases the brain isoform of glycogen phosphorylase: looking for a compensation mechanism in McArdle disease using a mouse primary skeletal-muscle culture in vitro.
de Luna N; Brull A; Guiu JM; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
Dis Model Mech; 2015 May; 8(5):467-72. PubMed ID: 25762569
[TBL] [Abstract][Full Text] [Related]
2. McArdle Disease: New Insights into Its Underlying Molecular Mechanisms.
Llavero F; Arrazola Sastre A; Luque Montoro M; Gálvez P; Lacerda HM; Parada LA; Zugaza JL
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31775340
[TBL] [Abstract][Full Text] [Related]
3. Expression of glycogen phosphorylase isoforms in cultured muscle from patients with McArdle's disease carrying the p.R771PfsX33 PYGM mutation.
Nogales-Gadea G; Mormeneo E; García-Consuegra I; Rubio JC; Orozco A; Arenas J; Martín MA; Lucia A; Gómez-Foix AM; Martí R; Andreu AL
PLoS One; 2010 Oct; 5(10):. PubMed ID: 20957198
[TBL] [Abstract][Full Text] [Related]
4. Phenotype consequences of myophosphorylase dysfunction: insights from the McArdle mouse model.
Brull A; de Luna N; Blanco-Grau A; Lucia A; Martin MA; Arenas J; Martí R; Andreu AL; Pinós T
J Physiol; 2015 Jun; 593(12):2693-706. PubMed ID: 25873271
[TBL] [Abstract][Full Text] [Related]
5. Results of an open label feasibility study of sodium valproate in people with McArdle disease.
Scalco RS; Stemmerik M; Løkken N; Vissing CR; Madsen KL; Michalak Z; Pattni J; Godfrey R; Samandouras G; Bassett P; Holton JL; Krag T; Haller RG; Sewry C; Wigley R; Vissing J; Quinlivan R
Neuromuscul Disord; 2020 Sep; 30(9):734-741. PubMed ID: 32811700
[TBL] [Abstract][Full Text] [Related]
6. Knock-in mice for the R50X mutation in the PYGM gene present with McArdle disease.
Nogales-Gadea G; Pinós T; Lucia A; Arenas J; Camara Y; Brull A; de Luna N; Martín MA; Garcia-Arumí E; Martí R; Andreu AL
Brain; 2012 Jul; 135(Pt 7):2048-57. PubMed ID: 22730558
[TBL] [Abstract][Full Text] [Related]
7. Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease.
Migocka-Patrzałek M; Elias M
Cells; 2021 Apr; 10(4):. PubMed ID: 33924466
[TBL] [Abstract][Full Text] [Related]
8. Investigating sodium valproate as a treatment for McArdle disease in sheep.
Howell JM; Dunton E; Creed KE; Quinlivan R; Sewry C
Neuromuscul Disord; 2015 Feb; 25(2):111-9. PubMed ID: 25455802
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylase re-expression, increase in the force of contraction and decreased fatigue following notexin-induced muscle damage and regeneration in the ovine model of McArdle disease.
Howell JM; Walker KR; Creed KE; Dunton E; Davies L; Quinlivan R; Karpati G
Neuromuscul Disord; 2014 Feb; 24(2):167-77. PubMed ID: 24309536
[TBL] [Abstract][Full Text] [Related]
10. Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease.
McNamara EL; Taylor RL; Clayton JS; Goullee H; Dilworth KL; Pinós T; Brull A; Alexander IE; Lisowski L; Ravenscroft G; Laing NG; Nowak KJ
Hum Mol Genet; 2020 Jan; 29(1):20-30. PubMed ID: 31511858
[TBL] [Abstract][Full Text] [Related]
11. McArdle disease: molecular genetic update.
Andreu AL; Nogales-Gadea G; Cassandrini D; Arenas J; Bruno C
Acta Myol; 2007 Jul; 26(1):53-7. PubMed ID: 17915571
[TBL] [Abstract][Full Text] [Related]
12. Differential Muscle Involvement in Mice and Humans Affected by McArdle Disease.
Krag TO; Pinós T; Nielsen TL; Brull A; Andreu AL; Vissing J
J Neuropathol Exp Neurol; 2016 May; 75(5):441-54. PubMed ID: 27030740
[TBL] [Abstract][Full Text] [Related]
13. The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology.
Migocka-Patrzałek M; Lewicka A; Elias M; Daczewska M
Int J Biochem Cell Biol; 2020 Jan; 118():105658. PubMed ID: 31747538
[TBL] [Abstract][Full Text] [Related]
14. Genes and exercise intolerance: insights from McArdle disease.
Nogales-Gadea G; Godfrey R; Santalla A; Coll-Cantí J; Pintos-Morell G; Pinós T; Arenas J; Martín MA; Lucia A
Physiol Genomics; 2016 Feb; 48(2):93-100. PubMed ID: 26465709
[TBL] [Abstract][Full Text] [Related]
15. The pathogenomics of McArdle disease--genes, enzymes, models, and therapeutic implications.
Nogales-Gadea G; Santalla A; Brull A; de Luna N; Lucia A; Pinós T
J Inherit Metab Dis; 2015 Mar; 38(2):221-30. PubMed ID: 25053163
[TBL] [Abstract][Full Text] [Related]
16. Low survival rate and muscle fiber-dependent aging effects in the McArdle disease mouse model.
Real-Martinez A; Brull A; Huerta J; Tarrasó G; Lucia A; Martin MA; Arenas J; Andreu AL; Nogales-Gadea G; Vissing J; Krag TO; de Luna N; Pinós T
Sci Rep; 2019 Mar; 9(1):5116. PubMed ID: 30914683
[TBL] [Abstract][Full Text] [Related]
17. Exercising with blocked muscle glycogenolysis: Adaptation in the McArdle mouse.
Nielsen TL; Pinós T; Brull A; Vissing J; Krag TO
Mol Genet Metab; 2018 Jan; 123(1):21-27. PubMed ID: 29174367
[TBL] [Abstract][Full Text] [Related]
18. Missense mutations have unexpected consequences: The McArdle disease paradigm.
García-Consuegra I; Asensio-Peña S; Ballester-Lopez A; Francisco-Velilla R; Pinos T; Pintos-Morell G; Coll-Cantí J; González-Quintana A; Andreu AL; Arenas J; Lucia A; Nogales-Gadea G; Martín MA
Hum Mutat; 2018 Oct; 39(10):1338-1343. PubMed ID: 30011114
[TBL] [Abstract][Full Text] [Related]
19. Generation of the First Human In Vitro Model for McArdle Disease Based on iPSC Technology.
Ortuño-Costela MDC; Cerrada V; Moreno-Izquierdo A; García-Consuegra I; Laberthonnière C; Delourme M; Garesse R; Arenas J; Fuster García C; García García G; Millán JM; Magdinier F; Gallardo ME
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430443
[TBL] [Abstract][Full Text] [Related]
20. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease?
de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T
Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
